Skip to main content
Back
Watch Compare

NP Life Sciences Health Industry Group Inc.

Data quality: 100%
ACAT
OTC Services Educational Services
$1.00
▼ $9.00 (-90.00%)
Mkt Cap: 77.21 M
Price
$1.00
Mkt Cap
77.21 M
Day Range
$1.00 — $1.00
52-Week Range
$0.54 — $10.00
Volume
2,500
Open $1.00
50D / 200D Avg
$10.00
90.00% below
50D / 200D Avg
$6.07
83.54% below

Quick Summary

Key Takeaways

ROE of 58.71% indicates high profitability
Generating 55,238.0 in free cash flow
P/E of 2660.93 — premium valuation
Cash machine — converts 190.36% of earnings into free cash flow
ROIC of 34.16% — excellent capital efficiency

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-38.04%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
58.71%
Above sector avg (-15.95%)
ROIC34.16%
Net Margin14.46%
Op. Margin25.80%

Safety

Debt / Equity
N/A
Current RatioN/A
Interest Coverage12943.00

Valuation

PE (TTM)
2660.93
Above sector avg (-1.17)
P/B Ratio2433.04
EV/EBITDA1489.81
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E 2660.9 -1.2
P/B 2433.0 1.4
ROE % 58.7 -16.0
Net Margin % 14.5 -19.4
Rev Growth 5Y % — 4.0
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -38.04% Revenue Growth (3Y) 70.73%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 200,634.0 Net Income (TTM) 29,018.0
ROE 58.71% ROA 24.24%
Gross Margin N/A Operating Margin 25.80%
Net Margin 14.46% Free Cash Flow (TTM) 55,238.0
ROIC 34.16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage 12943.00 Asset Turnover 1.68
Working Capital N/A Tangible Book Value 31,736
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2660.93 Forward P/E N/A
P/B Ratio 2433.04 P/S Ratio 384.85
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1489.81 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.07%
Market Cap 77.21 M Enterprise Value 77.13 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 190.36%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Revenue 102,002.0 164,621.0 34,992.0 15,000.0 43,000.0
Net Income -18,856.0 -2,935.0 -65,677.0 -131,065.0 -108,827.0
EPS (Diluted) — 0.00 — — —
Gross Profit — — — — —
Operating Income -18,855.0 -690.0 -65,681.0 -131,091.0 -108,859.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense -1.0 645.0 — — —
Income Tax — 1,600.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Total Assets 127,784.0 76,864.0 38,411.0 118,611.0 250,097.0
Total Liabilities 108,468.0 60,483.0 239.0 14,762.0 15,183.0
Shareholders' Equity 19,316.0 16,381.0 38,172.0 103,849.0 234,914.0
Total Debt — — — — —
Cash & Equivalents 121,859.0 70,614.0 27,986.0 118,611.0 242,933.0
Current Assets — — — — —
Current Liabilities — 38,121.0 — — —